SIBN NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Si-Bone Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 16.62 USD
-4.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 8.7% above the Trend Line and sits at 49.4% of its 52-week range. The latest completed week returned -4.4%, after a -4.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 39 out of 100
Latest Close 16.62 USD 24 Jul 2026
1W Return -4.4% latest completed week
4W Return -4.1% short-term follow-through
12W Return 25.8% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.4% Latest completed week; four-week move -4.1%. Indicator stack 10/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 59/100 conviction; expected move 14.4%. News sentiment 53/100 40 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 8.7% above the Trend Line and sits at 49.4% of its 52-week range. The latest completed week returned -4.4%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4612-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, 25.8% over 12 weeks, and -3.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.4%
4W-4.1%
12W25.8%
26W-1.1%
52W-3.7%
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change42.3%Four-week change in activity pressure.
Leadership-4.47Latest relative-leadership reading.
RS change18.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength7/100Blend of value, momentum, and quality. Underlying universe rank 94; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality25/100Profitability and accounting quality. Underlying universe rank 76; rank 1 is best.
Momentum25/100Medium-term price momentum. Underlying universe rank 76; rank 1 is best.
Growth77/100Revenue and earnings growth. Underlying universe rank 24; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
3.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
79.6%
Gross profit retained from each unit of revenue.
Operating margin
-6.9%
Operating profit retained from revenue.
Free-cash-flow margin
4.5%
Free cash flow generated from revenue.
Return on invested capital
-6.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
16.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
1187.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SIBN shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.00, expected move of 14.4%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move14.4%
Put/call volume0.00
Pressure100
Speculation41
Volatility82
Trend agreement0
Open options detail
Insider activity7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 40 relevant articles.

8 positive · 30 neutral · 2 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move14.4%Nearest-chain priced movement where available.
52-week drawdown-24.1%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+15.4%Week of 15 May.
Worst week-10.9%Week of 6 Mar.
Latest week-4.4%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks0
Modest losses9
Sharp losses6
Recent vol6.0%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis33/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.46; No reversal markers Factors17/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 45; Small Cap Core rank 87 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options38/100

SIBN shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.00, expected move of 14.4%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 14.4% Sentiment53/100

Weighted news tone is neutral across 40 relevant articles.

Earnings Preview: Si-Bone to Report Financial Results Post-market on August 03 Insiders7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202616.62 USD-4.4%15.30 USD16.37 USD0.97-4.471.9MOff
17 Jul 202617.38 USD-1.0%15.42 USD16.43 USD1.10-2.162.5MOff
10 Jul 202617.56 USD2.6%15.52 USD16.48 USD1.01-5.593.5MOff
3 Jul 202617.11 USD-1.3%15.55 USD16.53 USD0.84-6.833.3MOff
26 Jun 202617.33 USD9.4%15.64 USD16.59 USD0.68-5.483.5MOff
19 Jun 202615.84 USD2.7%15.71 USD16.65 USD0.43-18.052.1MOff
12 Jun 202615.42 USD2.0%15.83 USD16.73 USD0.35-18.681.6MOff
5 Jun 202615.12 USD7.2%15.90 USD16.81 USD0.37-19.122.7MOff
29 May 202614.10 USD-4.0%15.92 USD16.90 USD0.09-28.722.1MOff
22 May 202614.68 USD3.7%15.95 USD16.97 USD-0.06-24.582.9MOff
15 May 202614.16 USD15.4%15.97 USD17.04 USD-0.32-27.188.3MOff
8 May 202612.27 USD-7.1%15.99 USD17.11 USD-0.66-37.893.3MOff
1 May 202613.21 USD-2.3%16.08 USD17.19 USD-0.66-30.463.2MOff
24 Apr 202613.52 USD-4.0%16.12 USD17.25 USD-0.80-28.172.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.